135 related articles for article (PubMed ID: 23735902)
21. Iontophoretic transdermal delivery of ketoprofen: effect of iontophoresis on drug transfer from skin to cutaneous blood.
Tashiro Y; Kato Y; Hayakawa E; Ito K
Biol Pharm Bull; 2000 Dec; 23(12):1486-90. PubMed ID: 11145183
[TBL] [Abstract][Full Text] [Related]
22. Determination of the in vivo bioavailability of iontophoretically delivered diclofenac using a methyl nicotinate skin inflammation assay.
Lambrecht R; Clarys P; Clijsen R; Barel AO
Skin Res Technol; 2006 Aug; 12(3):211-6. PubMed ID: 16827697
[TBL] [Abstract][Full Text] [Related]
23. A novel method to enhance the efficiency of drug transdermal iontophoresis delivery by using complexes of drug and ion-exchange fibers.
Xin C; Li-hong W; Yue Y; Ya-nan G; Qi-fang W; Yang Y; San-ming L
Int J Pharm; 2012 May; 428(1-2):68-75. PubMed ID: 22405965
[TBL] [Abstract][Full Text] [Related]
24. In vivo determination of the diclofenac skin reservoir: comparison between passive, occlusive, and iontophoretic application.
Clijsen R; Baeyens JP; Barel AO; Clarys P
Drug Des Devel Ther; 2015; 9():835-40. PubMed ID: 25709408
[TBL] [Abstract][Full Text] [Related]
25. HPLC detection of plasma concentrations of diclofenac in human volunteers administered with povidone-ethylcellulose-based experimental transdermal matrix-type patches.
Mukherjee B; Mahapatra S; Das S; Roy G; Dey S
Methods Find Exp Clin Pharmacol; 2006 Jun; 28(5):301-6. PubMed ID: 16845447
[TBL] [Abstract][Full Text] [Related]
26. Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation.
Fouad SA; Basalious EB; El-Nabarawi MA; Tayel SA
Int J Pharm; 2013 Sep; 453(2):569-78. PubMed ID: 23792042
[TBL] [Abstract][Full Text] [Related]
27. Using laser microporation to improve transdermal delivery of diclofenac: Increasing bioavailability and the range of therapeutic applications.
Bachhav YG; Heinrich A; Kalia YN
Eur J Pharm Biopharm; 2011 Aug; 78(3):408-14. PubMed ID: 21397689
[TBL] [Abstract][Full Text] [Related]
28. Passive and iontophoretic delivery of three diclofenac salts across various skin types.
Fang J; Wang R; Huang Y; Wu PC; Tsai Y
Biol Pharm Bull; 2000 Nov; 23(11):1357-62. PubMed ID: 11085366
[TBL] [Abstract][Full Text] [Related]
29. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354
[TBL] [Abstract][Full Text] [Related]
30. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
31. In Depth Analysis of Pressure-Sensitive Adhesive Patch-Assisted Delivery of Memantine and Donepezil Using Physiologically Based Pharmacokinetic Modeling and in Vitro/in Vivo Correlations.
Mittapelly N; Pandey G; Tulsankar SL; Arfi S; Bhatta RS; Mishra PR
Mol Pharm; 2018 Jul; 15(7):2646-2655. PubMed ID: 29856631
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
33. Single dose pharmacokinetics of the novel transdermal donepezil patch in healthy volunteers.
Kim YH; Choi HY; Lim HS; Lee SH; Jeon HS; Hong D; Kim SS; Choi YK; Bae KS
Drug Des Devel Ther; 2015; 9():1419-26. PubMed ID: 25792802
[TBL] [Abstract][Full Text] [Related]
34. Influence of the formulation on the in vitro transdermal penetration of sodium diclofenac. Evaluation of the topical and systemic anti-inflammatory activity in the rat.
Calpena AC; Escribano E; San Martin H; Lauroba J; Obach R; Domenech J
Arzneimittelforschung; 1999 Dec; 49(12):1012-7. PubMed ID: 10635447
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo iontophoretic transdermal delivery of an anti-parkinsonian agent.
Vemulapalli V; Yang Y; Siddoju S; Conjeevaram R; Teunissen H; Myers T; Banga AK
Int J Pharm; 2011 Nov; 420(1):20-5. PubMed ID: 21856395
[TBL] [Abstract][Full Text] [Related]
36. Iontophoretic transdermal delivery of ketoprofen: novel method for the evaluation of plasma drug concentration in cutaneous vein.
Tashiro Y; Kato Y; Hayakawa E; Ito K
Biol Pharm Bull; 2000 May; 23(5):632-6. PubMed ID: 10823678
[TBL] [Abstract][Full Text] [Related]
37. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.
Kolli CS; Xiao J; Parsons DL; Babu RJ
Drug Dev Ind Pharm; 2012 May; 38(5):571-6. PubMed ID: 21980925
[TBL] [Abstract][Full Text] [Related]
38. Transdermal enhancement effect and mechanism of iontophoresis for non-steroidal anti-inflammatory drugs.
Zuo J; Du L; Li M; Liu B; Zhu W; Jin Y
Int J Pharm; 2014 May; 466(1-2):76-82. PubMed ID: 24607207
[TBL] [Abstract][Full Text] [Related]
39. Iontophoresis mediated in vivo intradermal delivery of terbinafine hydrochloride.
Sachdeva V; Kim HD; Friden PM; Banga AK
Int J Pharm; 2010 Jun; 393(1-2):112-8. PubMed ID: 20412843
[TBL] [Abstract][Full Text] [Related]
40. In vivo transdermal delivery of leuprolide using microneedles and iontophoresis.
Sachdeva V; Zhou Y; Banga AK
Curr Pharm Biotechnol; 2013; 14(2):180-93. PubMed ID: 23157712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
